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Background: Flexible bronchoscopy is one of the essential procedures for the diagnosis and treatment of pulmonary 
diseases. The purpose of this study was to identify the risk factors associated with the occurrence of hypoxia in adults 
undergoing flexible bronchoscopy under sedation.
Methods: We retrospectively analyzed 2,520 patients who underwent flexible bronchoscopy under sedation at our 
tertiary care university hospital in South Korea January 1, 2013–December 31, 2014. Hypoxia was defined as more 
than 5%-point reduction in the baseline percutaneous oxygen saturation (SpO2) or SpO2 <90% for >1 minute during the 
procedure.
Results: The mean age was 64.7±13.5, and 565 patients developed hypoxia during the procedure. The mean sedation 
duration and midazolam dose for sedation were 31.1 minutes and 3.9 mg, respectively. The bivariate analysis showed 
that older age, a low forced expiratory volume in one second (FEV1), use of endobronchial ultrasound, the duration 
of sedation, and the midazolam dose were associated with the occurrence of hypoxia during the procedure, while the 
multivariate analysis found that age >60 (odds ratio [OR], 1.32), a low FEV1 (OR, 0.99), and a longer duration of sedation 
(>40 minutes; OR, 1.33) were significant risk factors.
Conclusion: The findings suggest that patients older than age 60 and those with a low FEV1 tend to develop hypoxia 
during the bronchoscopy under sedation. Also, longer duration of sedation (>40 minutes) was a significant risk factor for 
hypoxia.
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Introduction
Flexible bronchoscopy is one of the most important pro-
cedures for diagnosis and treatment of pulmonary disease1. 
Bronchoscopy is also essential for mediastinal lymph node ex-
amination during nodal staging in patients with lung cancer2-5. 
For better patient tolerance, bronchoscopists can choose to 
perform the procedure under sedation6,7. However, bronchos-
copy under sedation is not easily performed in many hospitals 
because of the risk of several complications1,8, even though 
bronchoscopy itself is generally considered a safe procedure9. 
Complications of bronchoscopy include bleeding, pneumo-
thorax, fever, infection, and cardiac arrhythmia10-12. Although 
oxygen supplementation is routinely provided, hypoxia is a 
frequent event during bronchoscopy, particularly when seda-
tion is used13-15. It is generally transient and resolves instantly; 
however, the clinician should consider terminating the proce-
dure in cases where hypoxia persists for >1 minute1. Several 
studies have reported the risk factors associated with hypoxia 
during bronchoscopy for foreign body removal in children16,17. 
The findings of those studies indicated that the patient’s age 
and procedure duration were associated with the occurrence 
of hypoxia during bronchoscopy16,17. However, few studies 
have reported the risk factors for predicting hypoxia in elderly 
patients undergoing bronchoscopy under sedation. Accord-
ingly, the aim of this study was to identify the risk factors as-
sociated with hypoxia during flexible bronchoscopy under 
sedation in adult patients.
Materials and Methods
1. Study design
We retrospectively analyzed 3,508 patients aged >19 years 
who underwent flexible bronchoscopy under sedation at our 
tertiary care university hospital in South Korea between Janu-
ary 1, 2013 and December 31, 2014. Patients who underwent 
bronchoscopy without sedation (n=451) or with intubation 
(n=537) were excluded (Figure 1).
We collected all relevant data associated with bronchosco-
py under sedation, including baseline characteristics, pulmo-
nary function test (PFT) results, echocardiography findings, 
and chest computed tomography (CT) findings just before 
the procedure in order to evaluate their associations with the 
occurrence of hypoxia during the procedure. Several factors 
associated with the bronchoscopy procedure, including the 
type of procedure, durations of the procedure and sedation, 
doses of sedative drugs (midazolam and fentanyl), and di-
ameter of the bronchoscope, were also reviewed. The institu-
tional review board (IRB 4-2019-0274) of Severance Hospital 
approved this retrospective study and waived the need for 
informed consent.
2. Procedure and sedation
Bronchoscopy was performed under topical and intra-
venous anesthesia with spontaneous breathing. Before the 
procedure, 4% lidocaine spray was applied in the oral cavity 
for topical anesthesia. Sedative drugs, including midazolam 
(0.03–0.05 mg/kg) and 50 µg of fentanyl, were administered 
just before the procedure at the discretion of the bronchosco-
pist. With the patient in the supine position, the bronchoscope 
was inserted through the oral or nasal cavity depending on 
the patient’s condition. Then, 4% lidocaine was applied to 
the vocal cords, main carina, and both main bronchi through 
a channel of the bronchoscope. The target level of sedation 
was moderate so that patients could purposefully respond to 
verbal commands while maintaining a functional airway and 
cardiovascular function. The bronchoscopist used additional 
midazolam or fentanyl doses to maintain the level of sedation 
during the procedure. 
Hypoxia was defined as more than 5%-point reduction in 
the baseline percutaneous oxygen saturation (SpO2) or SpO2 
<90% for >1 minute during the procedure. The oxygen of 4 L/
min was applied through a nasal cannula to all patients be-
fore the bronchoscopy was started, and oxygen supplement 
was increased to 8 L/min in case of desaturation. If oxygen 
desaturation was not recovered despite maximal oxygen sup-
port, the procedure was stopped according to the decisions of 
bronchoscopist. Electrocardiograms and vital signs, including 
blood pressure, heart rate, and oxygen saturation, were con-
tinuously monitored during the procedure.
3. Statistical analysis
All data were statistically analyzed using SAS version 9.2 
(SAS Institute Inc., Cary, NC, USA). Categorical variables are 
presented as numbers with percentages and were analyzed 
Total (>19 years)
performed the flexible bronchoscopy
-
3,508 patients








565 Hypoxia 1,955 No hypoxia
Figure 1. Flow chart of the inclusion and the exclusion procedures 
for the study. A total of 3,508 patients were enrolled, and 2,520 were 
included in the analysis.
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using the chi-squared test. Continuous variables are pre-
sented as means±standard deviations and were evaluated 
using Student’s t-test. Multivariate logistic regression analysis 
was used to evaluate the association between risk factors and 
the development of hypoxia during the procedure, with the 
results presented as odds ratios (ORs) with 95% confidence 
intervals (CIs). A p-value of <0.05 was considered statistically 
significant. 
Results
1. Baseline characteristics of the study population
The study sample comprised of 1,585 men (62.9%) and 935 
women (37.1%). A total of 1,654 (65.6%) patients were >60 
years old, with a mean age of 64.7±13.5 years. With regard to 
the smoking status, 1,178 patients (46.7%) were never-smok-
ers and 1,342 (53.2%) were ever-smokers. The most common 
underlying disease was hypertension (36.7%). 
Tables 1 and 2 show the baseline characteristics of patients 
according to the occurrence of hypoxia during bronchoscopy 
under sedation. In total, 565 of the 2,520 patients (22.4%) 
developed hypoxia. The initial saturation level was not differ-
ent between the two groups. The proportion of patients aged 
>60 years was significantly higher in the desaturation group 
than in the no desaturation groups (p=0.003). There were no 
between-group differences in terms of sex, the smoking status, 
the history of smoking (pack-years), and prevalence of under-
lying diseases. Patients with hypoxia presented a significantly 
lower forced expiratory volume in 1 second (FEV1) just before 
the procedure (p=0.049) (Table 2). However, the forced vital 
capacity (FVC), FEV1/FVC ratio, and diffusing capacity of the 
lung for carbon monoxide (DLCO) were comparable between 
groups. Finally, there were no significant between-group dif-
ferences in terms of chest CT and echocardiography findings. 
Table 1. Baseline characteristics of patients stratified according to the occurrence of desaturation during flexible 
bronchoscopy under sedation
Variable No desaturation (n=1,955) Desaturation (n=565) p-value
Age, yr
   ≤60 701 (35.9) 165 (29.2)
   >60 1,254 (64.1) 400 (70.8) 0.003
Male sex 1,236 (63.2) 349 (61.7) 0.529
BMI, kg/m2 22.4±3.7 22.1±3.6 0.072
Smoking status
   Never-smoker 910 (46.5) 268 (47.4) 0.234
   Ever-smoker 1,045 (53.5) 297 (52.6)
History of smoking, pack-years 35.2±22.2 34.7±21.3 0.737
Underlying disease
   Hypertension 702 (35.9) 222 (39.3) 0.142
   Diabetes mellitus 382 (19.5) 123 (21.8) 0.243
   Chronic hepatitis 70 (3.6) 16 (2.8) 0.388
   Pulmonary tuberculosis 326 (16.7) 99 (17.5) 0.636
   Cardiovascular disease* 189 (9.7) 54 (9.6) 0.938
   Neuromuscular disease† 92 (4.7) 20 (3.5) 0.236
   Chronic kidney disease 47 (2.4) 16 (2.8) 0.566
   Malignancy‡ 476 (24.4) 159 (28.1) 0.067
   Chronic obstructive pulmonary disease 103 (5.3) 35 (6.2) 0.394
Values are presented as number (%) or mean±standard deviation.
*Cardiovascular disease includes coronary artery occlusive disease, arrhythmia, valvular heart disease, and congestive heart failure. †Neuro-
muscular disease includes cerebral infarction, cerebral hemorrhage, Alzheimer’s disease, Parkinson’s disease, epilepsy, and brain tumor. ‡Ma-
lignancy includes solid malignancy and hematological malignancy.
BMI: body mass index.
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2. Procedural factors associated with hypoxia 
development
In total, 86 patients (3.4%) underwent bronchoscopy with 
bronchoalveolar lavage (BAL), while 1,304 (51.7%) and 821 
(32.6%) patients underwent transbronchial lung biopsy and 
endobronchial ultrasound-guided transbronchial needle 
aspiration (EBUS-TBNA). The mean duration of sedation 
and mean dose of midazolam for sedation were 31.1±17.3 
minurwa and 3.9±2.4 mg. Table 2 shows the factors associated 
with bronchoscopy according to the occurrence of hypoxia 
during the procedure. The proportion of patients who under-
went EBUS-TBNA was significantly higher in the desaturation 
group than in the no desaturation group (p=0.001). There 
were no significant between-group differences for the other 
procedures. Moreover, the duration of sedation was signifi-
cantly longer (p<0.001) while the midazolam dose was signifi-
cantly higher (p=0.046) in the desaturation group than in the 
no desaturation group. There were no between-group differ-
ences in terms of the fentanyl dose, procedure duration, and 
Table 2. Comparison of various clinical and procedural findings according to the presence or absence of desaturation 
during flexible bronchoscopy under sedation
Variable No desaturation (n=1,955) Desaturation (n=565) p-value
Pulmonary function test
   FVC, % predicted 84.5±21.3 82.2±20.1 0.063
   FEV1, % predicted 87.3±24.2 84.5±23.4 0.049
   FEV1/FVC, predicted 73.8±12.3 73.0±12.4 0.294
   DLCO, % 91.0±25.8 90.0±28.8 0.625
Chest CT findings before procedure
   Emphysema 344 (17.6) 110 (19.5) 0.317
   Ground-glass opacity or honeycombing 154 (7.9) 50 (8.9) 0.463
   Consolidation 609 (31.2) 168 (29.7) 0.503
   Pleural effusion 249 (12.8) 79 (14.0) 0.448
   Bronchiectasis in at least two lobes 108 (5.5) 41 (7.3) 0.127
Echocardiography findings
   EF, % 64.0±9.6 63.1±10.9 0.276
   RVP, mm Hg 31.2±12.6 32.3±12.7 0.340
Type of procedure
   Bronchoalveolar lavage 68 (3.48) 18 (3.2) 0.741
   TBLB 1,011 (51.7) 293 (52.0) 0.921
   EBUS-TBNA 605 (31.0) 216 (38.3) 0.001
Factor associated with the procedure
   Clinician’s experience in the procedure, yr 2.24±1.42 2.31±1.37 0.299
   Duration of sedation, min
      <20 561 (28.7) 94 (16.6)
      20–30 526 (27.0) 125 (22.1)
      30–40 371 (19.0) 114 (20.2) <0.001
      >40 497 (25.4) 232 (41.1)
   Dose of midazolam, mg 3.84±1.39 3.98±1.54 0.046
   Dose of fentanyl, mg 47.7±14.2 48.4±12.9 0.287
   Bronchoscope with a large diameter 1,506 (77.4) 431 (77.0) 0.848
Values are presented as mean±standard deviation or number (%) unless otherwise indicated.
FVC: forced vital capacity; FEV1: forced expiratory volume in 1 second; DLCO: diffusing capacity; CT: computed tomography; EF: ejection 
fraction; RVP: right ventricular pressure; TBLB: transbronchial lung biopsy; EBUS-TBNA: endobronchial ultrasound–guided transbronchial 
needle aspiration.
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use of a bronchoscope with a large diameter.
We performed multivariate analysis to analyze factors that 
were significant in bivariate analysis, including age >60 years, 
low FEV1 in PFT, use of EBUS-TBNA, duration of sedation, 
and midazolam dose (Table 3). Age >60 years (OR, 1.32; 95% 
CI, 1.007–1.734), a low FEV1 in PFT (OR, 0.99; 95% CI, 0.989–
0.999), and a longer duration of sedation (>40 minutes; OR, 
1.33; 95% CI, 1.179–1.499) were significantly associated with 
the occurrence of hypoxia.
Discussion
The results of this study showed that an age of >60 years, a 
low FEV1, and a longer duration of sedation were significant 
predictors of the occurrence of hypoxia during bronchoscopy 
under sedation in adults.
Flexible bronchoscopy is an essential diagnostic and thera-
peutic procedure in respiratory medicine. However, it leads 
to coughing and discomfort in patients1. Sedation is used for 
not only surgery but also various other procedures8,18. Several 
patients are more comfortable undergoing endoscopy under 
sedation; therefore, gastrointestinal endoscopy is commonly 
performed under sedation19-21. In addition, there have been 
efforts to perform bronchoscopy under sedation, which is 
reportedly associated with increased patient and clinician sat-
isfaction6,22. Thus, bronchoscopy under sedation is generally 
recommended in the absence of any contraindications1,23.
However, several centers still do not use sedation during 
bronchoscopy because of the risk of side effects. Complica-
tions of bronchoscopy include bleeding, pneumothorax, 
fever, hypoxia, and cardiac arrhythmia10-12, and hypoxia is 
a common event during bronchoscopy under sedation. In 
most cases, it is transient and resolves quickly24-26, although 
the bronchoscopist may need to stop the examination and 
increase the oxygen supply or wake the patient during the pro-
cedure. If the hypoxia does not resolve, the procedure should 
be terminated27. A previous study reported that bronchoscopy 
under sedation provides comfort to the patient and bronchos-
copist28, while other studies evaluated drugs that are more 
effective for sedation during the procedure29,30. However, few 
studies have analyzed the risk factors for hypoxia during bron-
choscopy under sedation in adults15,31, although some have 
analyzed these risk factors for pediatric patients undergoing 
foreign body removal via bronchoscopy16,17. Determination 
of these risk factors for adult patients is important because of 
the widespread use of bronchoscopy, including interventional 
bronchoscopy7, and the increase in the number of elderly pa-
tients undergoing the procedure32. 
Silvestri et al.33 evaluated the use of fospropofol disodium 
for sedation in patients undergoing flexible bronchoscopy 
and reported that hypoxia was more frequent in older patients 
than in younger patients, although the difference was not sig-
nificant. In the present study, an age of >60 years was found 
to be significantly associated with the occurrence of hypoxia 
during bronchoscopy under sedation. Another significant risk 
factor was a low FEV1. Jones and O’Driscoll
24 also reported 
that the risk of desaturation during bronchoscopy was higher 
for patients with a lower FEV1, suggesting that those patients 
required oxygen supplementation during the procedure. Fi-
nally, Chen et al.17 reported that the longer duration of surgical 
procedure (>20 minutes) was correlated with intraoperative 
hypoxemia in young patients undergoing rigid bronchoscopy. 
And, Bittencourt et al.16 had also resulted that a longer proce-
dure time was vulnerable to a risk of hypoxemia in children. In 
our study result, we found that a longer duration of sedation 
(>40 minutes) was a significant risk factor for hypoxia.
In previous studies, bronchoscopy with BAL was related to 
the occurrence of hypoxia during the procedure34,35. This as-
sociation was not observed in the present study, probably be-
cause only 3.4% patients underwent bronchoscopy with BAL. 
Therefore, additional studies in a larger number of patients 
are necessary to evaluate the association between bronchos-
copy with BAL and hypoxia. Furthermore, there are several 
studies related to the risk of hypoxia during bronchoscopy in 
patients with severe chronic lung disease and heart failure36,37. 
However, in our study, there were no association between 
development of hypoxia and prevalence of underlying disease 
or results of chest CT and echocardiography. We only inves-
tigated the presence of underlying disease, so we could not 
reflect the severity of that disease. Therefore, further research 
about the risk of hypoxia during bronchoscopy with sedation 
Table 3. Multivariate analysis for predictors of hypoxia 
during flexible bronchoscopy under sedation
Variable OR 95% CI p-value
Age, yr
   Up to 60
   More than 60 1.322 1.007–1.734 0.044
Low FEV1, % predicted 0.994 0.989–0.999 0.013
EBUS-TBNA
   Yes 0.987 0.753–1.293 0.924
   No
Duration  of sedation, min
   <20 
   20–30
   30–40
   >40 1.329 1.179–1.499 <0.001
Midazolam dose 1.027 0.942–1.119 0.550
OR: odds ratio; CI: confidence interval; FEV1: forced expiratory vol-
ume in one second; EBUS-TBNA: endobronchial ultrasound–guided 
transbronchial needle aspiration.
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according to the severity of the disease is needed.
Our study has several limitations. First was the retrospec-
tive, single-center design. Second, subjective symptoms that 
can affect the occurrence of hypoxia, such as dyspnea, cough, 
and sputum, were not investigated. Third, although we inves-
tigated the total sedation time, the actual procedure duration 
was difficult to record because our analysis was retrospective. 
Fourth, we could not investigate the history of obstructive 
sleep apnea (OSA), although patients with OSA might be 
vulnerable to develop hypoxia during procedure with seda-
tion. Fifth, there is a statistically significant difference between 
FEV1% predicted and occurrence of hypoxia in our study. But 
the actual difference of is only 3% (87.3 vs. 84.5) between two 
groups. Most of the patients included in our study had normal 
lung function, and patients with less than 50% of predictive 
FEV1 values were only 4.8% of all patients. For this reason, 
these differences could not have clinically valuable meaning.
Nevertheless, this study also has its strengths. Our results 
were obtained for a large number of patients and can be used 
to predict the occurrence of hypoxia during bronchoscopy 
under sedation before the procedure. Thus, the bronchosco-
pist can evaluate the risk of hypoxia in advance and prepare 
any required devices, including a high-oxygen nasal cannula 
or noninvasive positive pressure ventilator, for patients exhib-
iting any of the risk factors. Maitre et al.38 and Heunks et al.39 
reported that the use of a noninvasive positive pressure ven-
tilator is useful during bronchoscopy in hypoxemic patients. 
Furthermore, Lucangelo et al.40 reported that a high-flow nasal 
interface could be effectively used in patients with mild respi-
ratory dysfunction during bronchoscopy. This can reduce not 
only patient discomfort but also the burden on the bronchos-
copist. However, further prospective studies are needed to 
validate our findings.
In conclusion, the results of this study suggest that age >60 
years, a low FEV1, and a longer duration of sedation (>40 min-
utes) are risk factors for hypoxia during bronchoscopy under 
sedation in adult patients. Therefore, patients with these risk 
factors should be prepared and cautioned about the compli-
cation before they undergo the procedure. Further prospec-
tive, multicenter studies are necessary to validate these find-
ings and improve the safety of bronchoscopy under sedation.
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